New patent for Eisai Inc drug DAYVIGO

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for DAYVIGO
Annual Drug Patent Expirations for DAYVIGO

Dayvigo is a drug marketed by Eisai Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

DAYVIGO drug price trends.

This drug has forty-nine patent family members in thirty-two countries.

The generic ingredient in DAYVIGO is lemborexant. One supplier is listed for this compound. Additional details are available on the lemborexant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top